PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

EMBARGOED: Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements

2025-02-19
(Press-News.org)

Study Title: Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

Publication: Science Translational Medicine

Dana-Farber Cancer Institute authors: Veronica Rendo, PhD, Eudocia Q. Lee, MD, MPH, Veronica Rendo, PhD Patrick Y. Wen, MD, Keith L. Ligon, MD, PhD, Rameen Beroukhim, MD, PhD

Summary: Clinical research by Dana-Farber scientists suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy. Navtemadlin is an MDM2 inhibitor that can help to kill cancer cells by boosting the activity of p53, a protein that controls cell growth and induces cell death in response to DNA damage. In lab experiments, the researchers found that navtemadlin was one of the best drugs at killing glioblastoma cells with intact, non-mutant p53. 

In this clinical trial, patients received navtemadlin, followed by surgery to remove tumor tissue, enabling the researchers to see how well the drug penetrated the tumor and understand its effects on cancer cells. They found that navtemadlin reached effective concentrations in the tumor and activated the p53 pathway, but the tumors eventually relapsed. The team then used tissue samples from three relapses and other patients to create patient-derived tumor models. They tested a range of navtemadlin dosing and combinations on these tumor models and found that combining navtemadlin with other DNA-damaging chemotherapy, such as temozolomide, could increase the rates at which cancer cells die. 

Significance: Glioblastoma is the most aggressive and most common malignant brain cancer in adults. It is currently treated with surgery, followed by radiation and chemotherapy. Prognosis is poor even with treatment. A challenge in conducting clinical trials in brain cancer is that it can be difficult to detect the cellular effects of new agents, as investigators are often limited to using imaging data and patient symptoms. This trial of navtemadlin sampled tumors on treatment, enabling the investigators to understand its effects in detail and conduct additional studies to optimize treatment strategies. This study suggests that a combination therapy strategy has the potential to increases the efficacy of navtemadlin and stave off resistance. 

Funding: National Institutes of Health, and the Massachusetts Life Sciences Center.

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber

2025-02-19
Boston - Kimberly Stegmaier, MD, was named Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital, in an announcement made today. Her appointment is effective April 1, 2025. Stegmaier, a Dana-Farber, Boston Children’s Hospital, and Harvard Medical School faculty member since 2002, Stegmaier is currently Vice Chair for Pediatric Oncology Research at Dana-Farber, Co-Director of the Pediatric Hematologic Malignancy Program at Dana-Farber and Boston Children’s Hospital, Co-Leader for the Dana-Farber/Harvard Cancer Center Leukemia Program, and a Professor ...

Human Immunome Project and Michelson Medical Research Foundation award $150,000 grants to three early-career scientists researching immunology and vaccines

Human Immunome Project and Michelson Medical Research Foundation award $150,000 grants to three early-career scientists researching immunology and vaccines
2025-02-19
NEW YORK – The Human Immunome Project (HIP) and Michelson Medical Research Foundation (MMRF) have awarded Dr. Omar Abudayyeh (Brigham and Women’s Hospital; Harvard Medical School), Dr. Caleb Lareau (Memorial Sloan Kettering Cancer Center), and Dr. Yuzhong Liu (Scripps Research) the 2024 Michelson Prizes: Next Generation Grants.    The $150,000 research grants are awarded annually to support early-career scientists advancing human immunology, vaccine discovery, and immunotherapy research for major global diseases.  “Investing in bold, early-career scientists fuels the high-risk, high-reward ideas ...

Devastating storms define Appalachia’s 2024 climate

Devastating storms define Appalachia’s 2024 climate
2025-02-19
After a year of weather extremes that brought everything from deadly floods to bitter cold, experts at East Tennessee State University have released a detailed analysis of the region’s 2024 weather patterns.   Their findings highlight both record-breaking temperatures and catastrophic storms – underscoring the growing need for preparedness as communities face unpredictable conditions.  The report, published by Tennessee’s Climate Office housed at ETSU, details how Southern Appalachia endured scorching heat and devastating floods, including the tragic September storm linked to ...

CRISPR manipulates plants’ flower powers

CRISPR manipulates plants’ flower powers
2025-02-19
Humans have appreciated the beauty of flowers for centuries. Yet, flowers aren’t just aesthetically pleasing. They also play a crucial role in plant reproduction. In all plants, a well-studied gene with a curious name, Unusual Floral Organs (UFO), orchestrates the flowering process. UFO expression hinges on another complex process called cis-regulation. And this one has remained a “black box” of plant biology research for years. Now, using CRISPR gene editing, Cold ...

Text message tool addresses “time toxicity” for cancer patients

2025-02-19
PHILADELPHIA – Cancer patients spend a lot of time on their care. Meeting with doctors and other members of their health care team, getting labs and other tests, picking up prescriptions, and undergoing treatment all takes time. So does getting to and from each appointment, sitting in the waiting room between each appointment, and so on. In recent years, cancer researchers have worked to quantify the level of “time toxicity” or time spent commuting to, waiting for, and receiving cancer treatment. Now, for the first time, a pilot study has shown it’s possible to use digital technology to safely ...

New therapy may effectively control HIV in Uganda

New therapy may effectively control HIV in Uganda
2025-02-19
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda. The study, published Jan. 30 in the Journal of Antimicrobial Chemotherapy, adds to growing evidence that lenacapavir may be a powerful new tool in the global anti-HIV drug arsenal. Approximately, 1.5 million people are living with HIV in Uganda. “Our data shows that only 1.6% of the individuals studied are living with HIV ...

Global retreat of glaciers has strongly accelerated

Global retreat of glaciers has strongly accelerated
2025-02-19
There are currently around 275,000 glaciers worldwide, in which huge quantities of fresh water are stored. But this reservoir is increasingly shrinking. Since the turn of the millennium, glaciers around the world – i.e. ice masses on land excluding the Greenland and Antarctic ice sheets – have lost around 273 billion tonnes of ice per year. This corresponds to about five and a half times the volume of Lake Constance. Overall, the world’s glaciers have lost around five per cent of their total volume since the year 2000. This is the conclusion reached by an international research team of which Tobias Bolch from the Institute of Geodesy ...

Data from all 50 states shows early onset breast cancer is on the rise in younger women: Does place of exposure matter?

2025-02-19
February 19, 2025-- Breast cancer incidence trends in U.S. women under 40 vary by geography and supports incorporating location information with established risk factors into risk prediction, improving the ability to identify groups of younger women at higher risk for early-onset breast cancer, according to a new study at Columbia University Mailman School of Public Health. This study comprehensively examined trends across different states, regions, metropolitan versus non-metropolitan areas and by racial and ethnic groups.  It also is one of the first to incorporate ...

California prison resentencing project yields modest results

2025-02-19
A three-year effort to encourage California prosecutors to reconsider the sentences given to some people in state prison has resulted in a modest number of people being resentenced, but improvements are needed to speed review of more cases, according to a new RAND report.   During the project involving nine counties, more than 1,100 cases received an initial review. After comprehensive reviews by county district attorneys for the suitability for resentencing, 227 individuals eventually received new sentences and 174 of those offenders had been released ...

Revealing the double-edged role of oxygen vacancy on ZrO2 catalysts in propane dehydrogenation

Revealing the double-edged role of oxygen vacancy on ZrO2 catalysts in propane dehydrogenation
2025-02-19
Propane dehydrogenation (PDH), as an efficient catalytic production process to obtain propylene, has developed rapidly in recent years. Previous studies have shown that zirconia exhibited excellent performance in the PDH, with the coordination-unsaturated zirconium (Zrcus) around the oxygen vacancy being the active site in the reaction. However, the critical role of oxygen vacancy is still remaining elusive, and lacked a rationale to establish a relation between structure and performance. Moreover, the strong binding of propene and hydrogen molecules shadowed ...

LAST 30 PRESS RELEASES:

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

Researchers discover new way cells protect themselves from damage

[Press-News.org] EMBARGOED: Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements